Collectively, these results indicated that the BLT2–ROS–NF-κB cascade is a previously unrecognized regulator of IL-8 production, and that such regulation controls the invasiveness of highly aggressive breast cancer cells. This evidence concerns the gene CXCL8 and breast cancer.